Please use this identifier to cite or link to this item:
http://sgc.anlis.gob.ar/handle/123456789/1619| DC Field | Value | Language |
|---|---|---|
| dc.date.accessioned | 2020-06-21T16:45:31Z | - |
| dc.date.available | 2020-06-21T16:45:31Z | - |
| dc.date.issued | 2020-06-18 | - |
| dc.identifier.uri | https://www.filo.news/ciencia/Investigadores-de-la-UNSAM-desarrollaron-un-suero-hiperinmune-contra-COVID-19-20200618-0021.html | - |
| dc.identifier.uri | http://sgc.anlis.gob.ar/handle/123456789/1619 | - |
| dc.description.abstract | El tratamiento, llevado a cabo enteramente en la Argentina y por científicos Argentinos, persigue la inmunización pasiva y consiste en administrar anticuerpos a los pacientes contra el agente infeccioso, produciendo su bloqueo y evitando que se propague. | en_US |
| dc.publisher | Filo.news | en_US |
| dc.subject | COVID19 | en_US |
| dc.subject | Medios de Comunicación | en_US |
| dc.subject | Suero Terapéutico COVID19 | en_US |
| dc.title | Investigadores de la UNSAM desarrollaron un suero hiperinmune contra COVID-19 | en_US |
| dc.type | Medios | en_US |
| item.cerifentitytype | Publications | - |
| item.openairetype | Medios | - |
| item.fulltext | With Fulltext | - |
| item.grantfulltext | open | - |
| item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
| Appears in Collections: | ANLIS frente a la epidemia COVID-19 | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Investigadores de la UNSAM desarrollaron un suero hiperinmune contra COVID.pdf | 424.4 kB | Adobe PDF |  View/Open |
Google ScholarTM
Check
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.